Follow-The-Filings

Security · featured owners

VYGR Voyager Therapeutics Inc.

COM Equity as of 2026 Q2 among managers we track

  • 1 Owner
  • Max 0.4%
  • $4M
  • 1 add

Who owns this now

Largest portfolio weights among featured holders · max 0.4% (James Silverman - Opaleye...) · not free-float ownership

  1. James Silverman add 0.38%

holders

sorted by value · long equity only · current book 2026 Q2 · open a manager for their book

history
James Silverman - Opaleye Management 2026 Q2 0.38% Add +3.0% 1,185,000 $4M history

1 current · options excluded

financials

US-GAAP annual · as tagged in Form 10-K · fiscal years · values link to the SEC filing

Income statement

Metric FY2023 FY2024 FY2025
Revenue $250.01M $80M $40.37M
Net income $132.33M -$65M -$119.72M
Net margin * 52.9% -81.3% -296.5%

Balance sheet

Metric FY2023 FY2024 FY2025
Total current assets $319.68M $276.81M $202.69M
Total non-current assets * $31.6M $116.24M $49.59M
Total assets $351.28M $393.05M $252.28M
Total current liabilities $64.51M $49.79M $26.54M
Total non-current liabilities * $50.45M $43.5M $29.66M
Total equity $236.32M $299.76M $196.08M

Cash flow

Metric FY2023 FY2024 FY2025
Cash from operations $77.92M -$15.31M -$132.47M
Cash from investing -$141.64M -$94.86M $125.45M
Cash from financing $33.64M $114.02M $816,000
Net change in cash -$30.08M $3.85M -$6.2M

Source: SEC companyfacts (US-GAAP 10-K) · * = computed (not a single XBRL tag) · fiscal year as labeled by the issuer · not adjusted or audited by Follow-The-Filings

ownership over time

filing count by report period · click a bar for that quarter’s holders